EVOQ Therapeutics

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Sol-Gel Hopes To Bring PellePharm’s Pat

Privately held EVOQ Therapeutics is using a new collaboration in autoimmune disease with Gilead Sciences, Inc. , along with a similar partnership inked with Amgen, Inc. , to get its NanoDisc deliv

Adendra Therapeutics, a company aimed at exploiting insights into dendritic cells to develop new cancer and autoimmune disease therapies, has been launched. The London, UK-based biotech company has be

Who: Amgen/Rodeo Therapeutics What: Amgen agreed to buy privately held Rodeo for $55m and potential earnouts. Why: In its second M&A deal of the year, Amgen acquired a company focused on therapie